跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
WINREVAIR 60 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
Approved
STANDARD
WINREVAIR 60 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
Merck Sharp & Dohme B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 2, 2024
Approval ID
3f15c2dca1c1bfdf
Company
Merck Sharp & Dohme B.V.
Type
Standard
Approval Details
Approval Id
3f15c2dca1c1bfdf
Drug Cima Aemps Name
WINREVAIR 60 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
Register Number
1241850003
Holder Company Name
Merck Sharp & Dohme B.V.
Marketing Company Name
Merck Sharp & Dohme De Espana S.A.
Holder Company Detail Path
/organization/merck-sharp-and-dohme-bv
Authorization Date
2024-09-02
Dosage Form
POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE
Dose
60 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Merck Sharp & Dohme B.V.
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Company Information
Pharmaceutical Company Name
Merck Sharp & Dohme BV
Country Name
Netherlands
Active Ingredients
SOTATERCEPT
60 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 2, 2024
Approval ID
3f15c2dca1c1bfdf
Type
Standard
Back to CIMA-AEMPS Approvals
WINREVAIR 60 MG POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details